PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6452155

Repeated patch testing in penicillin allergy.

D P Bruynzeel·W G van Ketel
View original source ↗Export metadata ↓

Abstract

Fifteen patients with positive patch test reaction to penicillin preparations were retested several times. This resulted in increasing reactions in eight out of fifteen patients and in decreasing reactions in five patients.

Explore related subjects

Drug EruptionsHumansPatch TestsPenicillinsSkin TestsTime FactorsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D P Bruynzeel, W G van Ketel. 1981. Repeated patch testing in penicillin allergy.. https://doi.org/10.1111/j.1365-2133.1981.tb00038.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Penicillamine-induced bullous dermatoses.

The successful therapeutic use of D-penicillamine (DPA) has been hindered by its many adverse effects. Autoimmune bullous syndromes are among the less common adverse DPA reactions; they are not dose dependent and appear late in the treatment of diseases of altered immunity, most often rheumatoid arthritis. The majority of the DPA-induced bullous syndromes belong to the pemphigus spectrum, usually pemphigus foliaceus or erythematosus, have a lower prevalence of demonstrable tissue-fixed or circulating antibodies than spontaneously occurring pemphigus, display abnormal direct immunofluorescent patterns, and have a generally favorable prognosis. However, many cases do exhibit a full-blown chronic disease, unaffected by DPA withdrawal. DPA-induced cicatricial pemphigoid is a severe disease of both mucous and cutaneous involvement with a prognosis similar to the spontaneous disease. Cases of DPA-induced epidermolysis bullosa acquisita and DPA-induced bullous pemphigoid were not sufficiently substantiated by immunofluorescence or immunoprecipitation criteria.

Drug Eruptions↗
PubMed1996

Lesions associated with drug reactions.

Several of the more common oral lesions secondary to medication use have been presented in this article. Although some of these conditions are specific to the oral tissues, some are not. Numerous cutaneous reactions to medications have mucosal counterparts. It is important for the clinician to recognize that many oral lesions are simply a manifestation of a systemic condition and should be managed with that in mind.

Drug Eruptions↗
PubMed1996

Immunologic mechanisms of cutaneous drug reactions.

Idiosyncratic reactions (type B) are a major complication of drug therapy, because they are related to both the drug and to individual factors in the host. In comparison with other organs, the skin is quite frequently a target of allergic reactions, which are mainly elicited by small molecular weight compounds. This is the case in allergic contact dermatitis as well as in drug allergic reactions. In contrast to allergic contact dermatitis however, drug-induced hypersensitivity reactions of the skin have enormous variability with regard to their pathophysiological pathways, clinical signs of symptoms, severity, and the drugs which can elicit these reactions. Allergic reactions are mediated either by specific antibodies or a cellular immunocompetent immune response. About 25% to 30% of type B reactions are estimated to be allergic drug reactions, which are classified by the latency period between the ingestion of the responsible allergen and the onset of clinical symptoms. Studying the mechanisms of these hypersensitivity reactions improves our understanding of these diseases in general, and shows the importance of the skin as a signaling organ in these reactions.

Drug Eruptions↗